Transseptal puncture for the treatment of structural heart disease: conventional needle or radiofrequency needle?

Courtesy of Dr. José Álvarez.

Transseptal Puncture for the Treatment of Structural Heart Disease: Conventional Needle or Radiofrequency Needle?This study sought to find differences in the transseptal puncture technique between the use of a conventional needle and the use of a radiofrequency-powered needle.

 

A total of 52 patients who underwent transseptal puncture for the treatment of various types of heart disease (Mitraclip, Watchman, Lariat, and mitral valvuloplasty) were retrospectively analyzed. A conventional needle was used in 25 cases (BRK, St Jude Medical) and a radiofrequency needle was used in the other 27 (Baylis Medical, Canada). All procedures included a transesophageal echocardiography; intended and actual puncture sites were analyzed in orthogonal views.

 

As a result, the puncture was effective in all cases in which a radiofrequency needle was used. As regards the conventional needle group, three patients required the use of an assistance wire to cross the septum and two patients had to be crossed over to the radiofrequency group. There were no differences as regards accuracy in the puncture site, but the time to septum crossing was lower for patients in the radiofrequency group. Septum tenting was higher in patients in the conventional needle group.

 

Editorial Comment

This is a retrospective observational study comparing two transseptal puncture techniques. Results were similar, except for a lower degree of septum tenting with a radiofrequency needle, which can be beneficial in cases in which the septum is lax and the conventional technique entails a risk of lesion to the left atrial lateral wall.

 

Courtesy of Dr. José Álvarez.

 

Original title: Accuracy and procedural characteristics of standard needle compared with radiofrequency needle transseptal puncture for structural heart interventions.

Authors: Gaufav Sharma MD, Gagan D Singh MD. Thomas Smith MD. Dali Fan MD, Reginald Low MD, Jason Rogers MD.

Reference: Cathet Cardiovasc Interv 2017; 89(6):E200-E206.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....